Authors: Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, Hlscher C
Share: GLP-1 medications commonly used to manage type 2 diabetes and obesity may be associated with a modest increase in hair loss, according to a study published by The BMJ on July 22, 2026
Darkness, low light or shade mostly reduces GST activity, while high or excess light significantly elevates both the activity and expression of GSTs and GSH levels
Kevin Sheng-Kai Ma, DDS, FRSPH, FRSM, international scholar at the Center for Global Health at the Perelman School of Medicine at the University of Pennsylvania and lead author of this study, told Medical News Today that he and his colleagues were not surprised by these findings, as these [obesity and obesity-related issues] are indications for GLP-1RA that have been approved in recent years. That said, clinicians are encouraged to monitor and continue assessing patients receiving GLP-1RA [drugs], he advised
While some side effects might resolve with time, these long-term effects deserve attention and communication with your healthcare provider for proper management and guidance
Supporting Your Liver and Skin The liver is the primary consumer of glutathione in the body